Trial Site Detail
Drug: |
QINLOCK
Ripretinib
DCC-2618 |
|||
|---|---|---|---|---|
Trial: |
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
Memorial Sloan Kettering1275 York Ave |
Principal Investigator: |
Robert Maki, MD |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Memorial Sloan Kettering Website: |
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.